High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 218-220

  Viladrich, Pedro F ^a,b   Cabellos, Carmen ^a   Pallares, Roman ^a   Tubau, Fe ^a   Martínez Lacasa, Javier ^a   Liñares, Josefina ^a   Gudiol, Francisco ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; DEXAMETHASONE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0030051169     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.218     Document Type: Article

References (28)

1. Alonso, J., V. Madrigal, and M. Garcia-Fuentes. 1991. Recurrent meningitis from a multiply resistant Streptococcus pneumoniae strain treated with erythromycin. Pediatr. Infect. Dis. J. 10:254-255.
2. Asensi, F., D. Pérez-Tamarit, M. C. Otero, M. Gallego, S. Llanes, C. Abadia, and E. Cantó. 1989. Imipenem-cilastin therapy in a child with meningitis caused by a multiply resistant pneumococcus, Pediatr. Infect. Dis. J. 8:895.
3. Bradley, J. S., and J. D. Connor. 1991. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to betalactam antibiotics. Pediatr Infect. Dis. J. 11:871-873
4. Cabellos, C., P. F. Viladrich, R. Verdaguer, R. Pallares, J. Lin̄ares, and F. Gudiol. 1995. A single daily dose of ceftriaxone for bacterial meningitis in adults: experience with 84 patients and review of the literature Clin. Infect Dis 20:1164-1168.
5. Canton, E. 1993. Cefotaxime breakpoint for Streptococcus pneumoniae. Antimicrob Agents Chemother. 37:616-617.
6. Catalan, M. J., J. M. Fernández, A. Vázquez, E. Varela de Seijas, A. Suárez, and J. C. L. Bernaldo de Quirós. 1994. Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin. Infect. Dis. 18:766-769.
7. Chapin-Rubertson, K., and S. C. Edberg. 1991. Measurement of antibiotics in human body fluids: techniques and significance, p. 295-366. In V. Lorian (ed), Antibiotics in laboratory medicine. 3rd ed. The William & Wilkins Co., Baltimore.
8. Friedland, I. R., and G. H. McCracken, Jr. 1994. Drug therapy: management of infections caused by antibiotic-resistant Streptococcus pneumoniae N. Engl. J. Med 331:377-382
9. Friedland, I. R., M. Paris, S. Ehrett, S. Hickey, K. Olsen, and G. H. McCracken, Jr. 1993. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob, Agents Chemother. 37:1630-1636
10. Friedland, I. R., S. Shelton, and G. H. McCracken, Jr. 1993. Screening for cephalosporin-resistant Streptococcus pneumoniae with the Kjrby-Bauer disk susceptibility test J. Clin. Microbiol. 31:1619-1621.
11. Friedland, I. R., S. Shelton, M. Paris, S. Rinderknecht, S. Ehrett, K. Krisher, and G. H. McCracken, Jr. 1993. Dilemmas in the diagnosis and treatment of cephalosporin-resistant pncumococcal meningitis. Pediatr. Infect. Dis. J. 12: 196-200
12. Jacobs, M. R., Y. Mithal, R. N. Robins-Browne, M. N. Gaspar, and H. J. Koornhof. 1979. Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erithromycin, clindamycin, tetracycline, chloramphenicol, and rifampin. Antimicrob. Agents Chemother. 16:190-197
13. John, C. C. 1994 Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review Clin. Infect. Dis. 18:188-193.
14. Jorgensen, J. H., G. V. Doern, M. J. Ferraro, C. C. Knapp, J. M. Swenson, and J. A. Washington. 1992. Multicenter evaluation of the use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae and development of quality control limits. J. Clin Microbiol. 30:961-966.
15. Lecaillon, J. B., M. C. Rouan, C. Souppart. N. Fevre, and F. Juge. 1982. Determination of cefsulodine, cefotiam. cephalexine, cefotaxime. desaceryl-cefotaxime, cefuroxime and cefroxadin m plasma and urine by high-performance liquid Chromatography. J. Chromatogr 228:257-267.
16. Liñares, J., T. Alonso, J. L. Pérez, J. Ayats, M. A. Dominguez, R. Pallarés, and R. Martín. 1992. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics. J. Antimicrob. Chemother 30:279-288.
17. Linares, J., R. Pallares, T. Alonso, J. L. Pérez, J. Ayats, F. Gudiol, P. F. Viladrich, and R. Martin. 1992. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin. Infect. Dis. 15:99-105.
18. Lonks, J. R., M. R. Durkin, A. N. Meyerhoff, and A. A. Medeiros. 1995. Meningitis due to ceftriaxone-resistant Streptococcus pneumoniae. N. Engl J Med 332:893-894.
19. National Committee for Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2, 2nd ed. National Committee for Clinical Laboratory Standards, Villanova, Pa.
20. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3, 3rd ed. National Committee for Clinical Laboratory Standards, Villanova, Pa.
21. National Committee for Clinical Laboratory Standards. 1994. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3, 3rd ed. NCCLS document, vol. 14, No. 16. National Committee for Clinical Laboratory Standards, Villanova, Pa.
22. Paris, M., S. M. Hickey, M. I. Uscher, S. Shelton, K. D. Olsen, and G. H. McCracken, Jr. 1994. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis Antimicrob. Agents Chemother 38:1320-1324.
23. Parras, F., M. E. García Leoni, P. Muñoz, T. Peláez, M. Rodriguez-Creixems, and E. Bouza. 1993. Therapy with IV and intrathecal (IT) vancomycin for penicillin-resistant S. pneumoniae meningitis, abstr. 1149, p. 330. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington. D.C.
24. Sloas, M. M., F. F. Barrett, P. J. Chesney, B. K. English, B. C. Hill, F. C. Tenover, and F. J. Leggiaro. 1991. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr. Infect Dis. J. 11:662-666.
25. Stratton, C. W. Comment. 1993. Infect Dis. Newsl. 12:39
26. Tunkel, A. R., B. Wispelwey, and W. M. Scheld. 1990. Bacterial meningitis recent advances m pathophysiology and treatment. Ann Intern. Med. 112: 610-623.
27. Viladrich, P. F., F. Gudiol, J. Lińares, R. Pallares, I. Sabaté, G. Rufí, and J. Ariza. 1991. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother. 35:2467-2472.
28. Viladrich, P. F., F. Gudiol, J. Lińares, G. Rofí, J. Ariza, and R. Pallarés. 1988. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am. J. Med 84:839-846.